Myovant Sciences Ltd. Deferred Tax Assets, Net of Valuation Allowance
Myovant Sciences Ltd. had Deferred Tax Assets, Net of Valuation Allowance of $2.27 million as of 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2022-05-11
- 2022-03-31: Deferred Tax Assets, Net of Valuation Allowance $2.27M.
- 2021-03-31: Deferred Tax Assets, Net of Valuation Allowance $2.69M.
- 2017-03-31: Deferred Tax Assets, Net of Valuation Allowance $208.00K.
- 2016-03-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2022-03-31 | $2.27M 10-K · filed 2022-05-11 |
| 2021-03-31 | $2.69M 10-K · filed 2022-05-11 |
| 2017-03-31 | $208.00K 10-K · filed 2017-06-14 |
| 2016-03-31 | $0.00 10-K · filed 2017-06-14 |